InvestorsHub Logo
Followers 572
Posts 14186
Boards Moderated 0
Alias Born 03/25/2005

Re: jfkspire post# 7681

Tuesday, 12/22/2015 9:36:55 AM

Tuesday, December 22, 2015 9:36:55 AM

Post# of 74472
This is EXACTLY What I was Talking About-in my post on the 18th (link below) When I was talking about the Link Between BIEI and BMY (Bristol Mysers Squibb), Here is a copy of what I wrote Below.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119285891&txt2find=bmy

EXCEPT I forgot to Mention the Fact that BIEI's Unique Antibody is 3X MORE EFFECTIVE!

This Puts BIEI on the Same Playing Field in the Research & Development & Science of this as the ONLY Competition that BMY Has.


Can Anyone Actually Fathom just How HUGE This can actually be for BIEI??

"BMY IS A $114 BILLION MARKET CAP COMPANY"
Compared with
"BIEI which is Currently a $3 MILLION MARKET CAP COMPANY"

Since BIEI has Come-up with a Different Molecule than Bristol, Myers, Squibb. And BIEI is their ONLY Competition in this area, and BMY's Newly FDA Approved drug Yervoy is based on the same type of Science and which is Estimated at $5 BILLION in Revs for 2016, the only way BMY can get rid of their Competition "BIEI" Would be to BUY BIEI OUT!

This is SO MUCH Bigger than anyone has any idea of.

A Company that can be in Comparison with BIEI, only Difference/Problem is that BIEI Got Mixed up with Toxic Financiers, if BIEI had never gotten any Toxic debt, the Stock would have never been shorted down like it was from the Double Digits.

The Company to compare with BIEI is CTSO. After checking it out, IMO BIEI Has Much More Potential than CTSO & is on the NASDAQ Trading at $7 Bucks.

IMO, BIEI Just has not been Recognized for what they have done yet, BUT It's coming, IMO.

BIEI PR about their unique antibody. BIEI is basically BMY's only Competition in this area.

https://finance.yahoo.com/news/university-texas-el-paso-utep-141500881.html

BMY's PR FDA Approval unique antibody drug Vervoy Est. $5 BIL Revs next year. BIEI is BMY's only real Competition in this area.
http://news.bms.com/press-release/financial-news/bristol-myers-squibb-receives-approval-us-food-and-drug-administration-


A TOXIC LENDER